Advanced Infusion Solutions (AIS) Pharmaceutical Manufacturing Ridgeland, Mississippi 51 followers Follow View all 33 employees About us AIS HealthCare the leading provider of advanced sterile,. Pasar al contenido principal LinkedIn. These allegations are sufficient to plausibly state a claim for breach of good faith and fair dealing. (dba The Wellness Pharmacy), Winchester, VA- 503A Facility, Kalman Health & Wellness, Inc. (dba Essential Wellness Pharma), Peoria, IL- 503A Facility, Kelley-Ross Compounding Pharmacy, Seattle, WA- 503A Facility, Key Compounding Pharmacy (see Puget Sound Drug Corporation), Federal Way, WA- 503A Facility, Keystone Pharmacy, Grand Rapids, MI- 503A Facility, Keystone Rx LLC, Bensalem, PA- 503A Facility, Kings Park Slope, Inc., Brooklyn, NY- 503A Facility - De-registered as an Outsourcing Facility, Kohana Pharmacy and Center for Regenerative Medicine Inc., San Luis Obispo, CA- 503A Facility, Kohll's Compounding, Omaha, NE- 503A Facility, Kona Community Hospital Pharmacy, (see Hawaii Health Systems Corporation), Kealakekua, HI- 503A Facility, KRS Global Biotechnology, Inc. Boca Raton, FL- 503B Facility, Ladd Family Pharmacy LLC, Boise, ID- 503A Facility, Lato Drug Company, Inc. (dba Post Haste Pharmacy), Hollywood, FL- 503A Facility, La Vita Compounding Pharmacy, LLC, San Diego, CA- 503A Facility, Lee and Company (dba Lee Pharmacy, Inc.), Fort Smith, AR- 503A Facility - Out of business, Lee Pharmacy, Inc.(see Lee and Company), Fort Smith, AR- 503A Facility, LeeSar, Inc., Fort Myers, FL- 503B Facility, Lee Silsby Compounding Pharmacy, (see Gipsco Investment Corp.), Cleveland Heights, OH- 503A Facility, Leiter's Cambrian Park Drugs, Inc., (dbaLeiter's Compounding Pharmacy), 1700 Park Avenue, San Jose, CA- 503A Facility - Out of business, Leiter's Compounding, 17 Great Oaks Blvd., San Jose, CA- 503A Facility, Leiter's Compounding Pharmacy,(see Leiter's Cambrian Park Drugs, Inc.), San Jose, CA- 503A Facility, Leiter's Health, (see Denver Solutions, LLC), Englewood, CO- 503A Facility, Liberty Drug and Surgical, Chatham, NJ- 503A Facility, Life Science Pharmacy, Inc., Harriman, NY- 503A Facility, Lifetime Value Pharmacy III Inc., Santa Ana, CA- 503A Facility, Lincare, Inc. (dba United Medical Home Infusion), Little Rock, AR- 503A Facility, Lloyd Central Compounding Pharmacy, (see Portland Compounding Pharmacy, LLC), Portland, OR- 503A Facility, Loop Pharmacy & Home Medical, Saint Albans, WV- 503A Facility, Louisville Pharmacy (see Spoonamore Drug Co., Inc.), Louisville, KY- 503A Facility, Lowlite Investments, Inc. (dba Olympia Pharmacy), Orlando, FL- 503A Facility, Lowlyn Pharmacies, Inc. (dba Red Cross Drug), Blanchard, OK- 503A Facility, Lynnfield Drug, Inc. (dba Freedom Fertility Pharmacy), Byfield, MA- 503A Facility, Lynn Oaks Compounding Pharmacy, Thousand Oaks, CA - 503A Facility, M Drug, LLC, (dba Northern Light Pharmacy), Bangor, ME- 503A Facility, Maag Prescription Center LLC, Pocatello, ID- 503A Facility, Madison Drugs (see Service First Pharmacies, Inc.), Huntsville, AL- 503A Facility, Magellan Rx Pharmacy LLC, Astoria, NY- 503A Facility, Maimonides Medical Center-Pharmacy, Brooklyn, NY- 503A Facility, Main Street Family Pharmacy, Newbern, TN- 503A Facility - Out of business, Maitland Labs of Central Florida, Orlando, FL- 503A Facility - Out of business, Malley's Compounding Pharmacy, (see Columbia River Pharmacy, LLC), Richland, WA- 503A Facility, Malanda, Inc., (dba Mandell's Clinical Pharmacy), Somerset, NJ- 503A Facility, Maplerose Enterprises, LLC (dba Pencol Pharmacy), Denver, CO- 503A Facility, Mark Drugs Pharmacy, (see Snyder Mark Drugs Roselle, Inc.), Roselle, IL- 503A Facility, Martin Avenue Pharmacy, Inc., Naperville, IL- 503A Facility, Maryland Specialty and Compounding, LLC dba Professional Arts Pharmacy, Baltimore, MD- 503A Facility - Ceased sterile compounding, MasterPharm LLC. advanced infusion solutions lawsuit. [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021), U.S. Courts Of Appeals | Contract | These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia. AIS sued BCBS and AHS, asserting breach of contract, breach of implied duty of good faith and fair dealing, unjust enrichment, breach of implied-in-fact contract, and failure to provide benefits under ERISA plans, and seeking declaratory judgment that it is entitled to payment. Fax: 601-988-1701. Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. Release of Transcript Restriction set for 10/4/2021. R. Civ. [47] 54. Thus, the Court denies AIS's motion on this claim. Date of service: 10/19/2021. advanced infusion solutions lawsuitdelpark homes sutton advanced infusion solutions lawsuit. Ct. App. Rule 9(b) requires a party to plead with particularity the circumstances constituting fraud. 1:23-CV-00409 | 2023-01-27, U.S. District Courts | Other | For the reasons stated, the Court DENIES AIS's Motion to Dismiss Counterclaim [56]. 3:11 . "A breach is material where there is `a failure to perform a substantial part of the contract or one or more of its essential terms or conditions, or if there is such a breach as substantially defeats [the purpose of the contract].'" Blue Cross Blue Shield of Michigan v. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, US District Court for the Eastern District of Michigan, Minute Entry for proceedings before District Judge Denise Page Hood: Motion Hearing held on 6/23/2021 re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Disposition: Motion taken under advisement (Court Reporter: Sheri Ward) (LSau). Fed. Supplemental Electronic ROA due on 11/08/2021. Advanced Infusion Solutions (AIS) Pharmaceutical Manufacturing Ridgeland, Mississippi 41 followers See jobs Follow View all 32 employees Report this company About us AIS HealthCare the leading provider of advanced sterile, patient-specific intrathecal pump medications and in-home intravenous infusion including immune globulin therapies. No. (Entered: 04/08/2021), (#17) STIPULATED ORDER Regarding Motions. Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary Xavier Becerra on Friday jointly asked U.S . Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. 2:19-CV-02695 | 2019-06-20, U.S. District Courts | Civil Right | Supply v. Boyles, Moak & Brickell Ins.,822 So.2d 323, 330 (Miss. Receipt No: AMIEDC-8266539 - Fee: $ 402. Defendant / Appellee: Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Plaintiff: Blue Cross Blue Shield of Michigan: Defendant: Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions: Case Number: 2:2021cv10076: Filed: January 11, 2021: Court: US District Court for the Eastern District of Michigan: Presiding Judge: The basis for the action "lies in a promise, which is implied in law, that one will pay to the person entitled thereto [that] which in equity and good conscience is his." Before the Court is Advanced Infusion Solutions' ("AIS") Motion to Dismiss the Counterclaim filed by Blue Cross & Blue Shield of Mississippi ("BCBS") and Advance Health Systems ("AHS") [56]. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. D/B/A ADVANCED INFUSION CARE Court:United States District Court, Eastern District of Louisiana Date published: Jul 30, 2021 CitationsCopy Citation Civil Action 21-774 (E.D. The system is commonly used in hospitals and. (Entered: 01/28/2021), Docket(#4) ATTORNEY APPEARANCE: Scott R. Knapp appearing on behalf of Blue Cross Blue Shield of Michigan (Knapp, Scott) (Entered: 01/21/2021), Docket(#3) SUMMONS Issued for *Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions* (NAhm) (Entered: 01/12/2021), Docket(#2) STATEMENT of DISCLOSURE of CORPORATE AFFILIATIONS and FINANCIAL INTEREST by Blue Cross Blue Shield of Michigan (Moody, Nolan) (Entered: 01/11/2021), Docket(#1) COMPLAINT filed by Blue Cross Blue Shield of Michigan against Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Healthy snacks. 13. 13. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), Docket(#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. (Winsten, I.) Advanced Pain Management's clinic at 4448 W. Loomis Road in Greenfield. Flaherty & Crumrine Preferred Income Fund Inc. v. TXU Corp.,565 F.3d 200, 206-07 (5th Cir. And by breaching the Agreement, AIS caused BCBS to wrongfully pay the S9328 code. Blog (Entered: 01/28/2021), (#4) ATTORNEY APPEARANCE: Scott R. Knapp appearing on behalf of Blue Cross Blue Shield of Michigan (Knapp, Scott) (Entered: 01/21/2021), (#3) SUMMONS Issued for *Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions* (NAhm) (Entered: 01/12/2021), (#2) STATEMENT of DISCLOSURE of CORPORATE AFFILIATIONS and FINANCIAL INTEREST by Blue Cross Blue Shield of Michigan (Moody, Nolan) (Entered: 01/11/2021), (#1) COMPLAINT filed by Blue Cross Blue Shield of Michigan against Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. (Werner, Paul) (Entered: 03/11/2021), Docket(#9) MOTION for Default Judgment as to Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions by Blue Cross Blue Shield of Michigan. 47. No. [21-30534] (DLJ) [Entered: 08/27/2021 12:27 PM]. Id. 1992) (citation omitted). [21-30534] (Roberta Louise Burns ) [Entered: 09/14/2021 10:55 AM], APPEARANCE FORM for the court's review. Signed by District Judge Denise Page Hood. The elements of intentional misrepresentation are: Hobbs Auto., Inc. v. Dorsey,914 So.2d 148, 153 (Miss. (Winsten, I.) If no request is filed, the transcript may be made remotely electronically available to the public without redaction after 90 days. Ferrara v. Walters,919 So.2d 876, 886 (Miss. Accepting these allegations as true, BCBS and AHS have plausibly stated both elements for breach of contract. (Entered: 05/12/2021), Docket(#23) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. . BCBS and AHS, on the other hand, allege the Agreement permitted AIS to bill a per diem rate under the S9328 code "when it performed intrathecal pain pump fill/refills or other infusions in the [m]ember's home or equivalent setting and provided ongoing services, such as medical supervision, care coordination, nursing, patient or caregiver training, and patient support." Use the links below to access additional information about this case on the US Court's PACER system. Case Number: 21-30534. Home Infusion Therapy Pharmacy. This Court has considered all the parties' arguments. 16. Id. Advanced Infusion Solutions, (see Bond Pharmacy, Inc. ), Ridgeland, MS - 503A Facility Advanced Nutriceuticals, LLC, Indianapolis, IN - 503A Facility Warning Letter (11/10/2021) 483 Issued. Mailing Address: PMB 507 1353 Rd. All rights reserved ), Winchester, VA- 503A Facility, Thrifty White Drug #762, Minneapolis, MN- 503A Facility, Thrive Pharmacy, (see Matthew 7:25 Inc), Jacksonville, FL- 503A Facility, Tiberius, Inc., dba Custom Scripts Pharmacy, Wesley Chapel, FL- 503A Facility, Total Pharmacy Services, Houma, LA- 503A Facility, Total Vein Pharmacy, LLC, (dba Total Vein Pharmacy), Houston, TX- 503A Facility, Tower Pharmacy and Compounding, (see Botrosons Pharmaceutical Inc.), Mission Viejo, CA- 503A Facility, Town and Country Compounding and Consultation Services LLC, Ridgewood, NJ- 503A Facility, Town Total Compounding Center, Melville, NY- 503A Facility, Transdermal Therapeutics, Inc., Birmingham, AL- 503A Facility, Triad Isotopes, Inc., (see Jubilant DraximageRadiopharmacies, Inc.),Kansas City, MO- 503A Facility, Triad Rx, Inc., Daphne, AL- 503A Facility, Triangle Compounding, Cary, NC- 503A Facility - De-registered as an Outsourcing Facility, Tri-Coast Pharmacy Inc., Juno Beach, FL- 503A Facility - Out of business, Tri-Med, Inc., (dba Advanced Care Infusion-Shelby), Shelby Township, MI- 503A Facility, Trinity Care Solutions(see Franck's Lab, Inc.), Ocala, FL- 503A Facility, Trone Health Services, Inc. (Medicap Pharmacy), Meridian, ID- 503A Facility, TSDR Pharmacy, Inc. (dba brandMD Skin Care), Chatsworth, CA- 503A Facility, UCSF Home Therapy Services, San Francisco, CA- 503A Facility, Unique Pharmaceutical, Ltd., Temple, TX- 503A Facility - Out of business, United Pharmacy, LLC, West Palm Beach, FL- 503A Facility - Out of business, University Compounding Pharmacy,(see Diversified Pharmacy Inc.), Troy, MI- 503A Facility, University of Michigan, Ann Arbor, MI- 503A Facility, University of Washington Medical Center Inpatient Pharmacy, Seattle, WA- 503A Facility, University Pharmacy, Inc., Salt Lake City, UT- 503A Facility, University Rx Specialties Inc., San Diego, CA- 503A Facility, US Compounding Inc., Conway, AR- 503A Facility - Out of business, US Specialty Formulations LLC, Bethlehem, PA- 503B Facility, VA New Jersey Health Care System, East Orange, NJ- 503A Facility, Valgene Incorporated, (dba Cape Drugs), Annapolis, MD- 503A Facility, Valescent Compounding Inc. dba VPI Compounding,Centennial, CO - 503A Facility, Valor Compounding Pharmacy, Inc., dba Valor Compounding Pharmacy, Berkeley, CA - 503A Facility, Vann Healthcare Services, Inc., Glasgow, KY- 503A Facility, Vasco Pharmacy (see Vitalab Pharmacy, Incorporated), Phoenix, AZ- 503A Facility, Village Compounding Pharmacy, Houston, TX- 503A Facility, Village Fertility Pharmacy, Inc., Waltham, MA- 503A Facility, Village Pharmacy, Allentown, NJ- 503A Facility, Vita Pharmacy, LLC, (dba Talon Pharmacy of Boerne), Boerne, TX- 503A Facility, Vita Pharmacy, LLC, (dba Talon Compounding Pharmacy), San Antonio, TX- 503A Facility, Vitalab Pharmacy, Incorporated (dba Vasco Pharmacy), Phoenix, AZ- 503A Facility, Vital Care Compounder LLC, (see Pharmacy Plus, Inc.), Hattiesburg, MS- 503A Facility, Vital Care of Dickson, Dickson, TN- 503A Facility, Vital Rx, Inc. dba Atlantic Pharmacy and Compounding, Pompano Beach, FL- 503A Facility - Out of business, W & C (dba The Apothecary), Sartell, MN- 503A Facility, Walgreens Home Care, Inc. dba Walgreens Infusion Services, San Antonio, TX- 503A Facility, Walgreens Infusion Services, Houston, TX- 503A Facility, Walter's Pharmacy, Allentown, PA- 503A Facility, Weatherford Compounding Pharmacy, LLC, Weatherford, TX- 503A Facility, Wedgewood Connect, LLC, San Jose, CA- 503B Facility, Wedgewood Village Pharmacy, Inc., Swedesboro, NJ- 503A Facility -Ceased Compounding Human Drug Products, Well Care Discount Pharmacy LLC, (dba Well Care Compounding Pharmacy), Las Vegas, NV- 503A Facility, Wellcare Rx Investments, (dba Denson's Specialty Pharmacy), Wheaton, IL- 503A Facility, Wellness Pharmacy, Inc., Birmingham, AL- 503A Facility, WellRx, LLC (dba HomeRx, LLC), Wheaton, IL- 503A Facility, Wells Pharmacy Network, LLC, Ocala, FL- 503A Facility, Wells Pharmacy Network LLC, Dyersburg, TN- 503B Facility, Wells Pharma of Houston LLC, Houston, TX- 503B Facility, West Coast Nuclear Pharmacy, LLC, Tampa, FL- 503A Facility, Western Drug Inc. dba Western Drug and General Store, Springerville, AZ- 503A Facility, Westlab Pharmacy, Inc., (dba Westlab Pharmacy), Gainesville, FL- 503A Facility, White House Pharmacy, Inc., (dba San Jose Compounding Pharmacy), San Jose, CA- 503A Facility, Wickliffe Pharmaceutical, Inc., Lexington, KY- 503A Facility, Wiley Chemists, Inc., Santa Fe, NM- 503A Facility, William R. Grace M.D. Video/Audio Exhibits on File in District Court? (LSau) (Entered: 04/06/2021), (#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Filed: August 27, 2021. 815 F.Supp.2d 966 (2011) BOND PHARMACY, INCORPORATED, Doing Business as Advanced Infusion Solutions, Plaintiff, v. ANAZAOHEALTH CORPORATION, Defendant.